1 authorship bernard lo, m.d. august 23 and september 2, 2010

55
1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

Post on 20-Dec-2015

214 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

1

Authorship

Bernard Lo, M.D.

August 23 and September 2, 2010

Page 2: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

2

Survey of UCSF fellows

Omitted as author 20%

Co-author didn’t deserve it 38%

Asked to make someone author who

didn’t deserve it 37%

Page 3: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

3

Case 1: Prior agreements fail

Participants enrolled, data collected

and entered into statistical program

First author not analyzing data or

writing paper

You want to take lead, get paper out

Page 4: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

4

Case 1: Prior agreements fail

What would you do? Send an ultimatum to your colleague Get your mentor to pressure him Forget about the project and move on Not sure

Page 5: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

5

Case 2: Added author

Division chief asks to be author

Comments in seminars and on abstract

Not participate in design or analysis

Page 6: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

6

Case 2: Added author

What would you do? Hold your nose and do it Ask your department chair to intervene Refuse and stand up for your principles Forget about the project and move on Not sure

Page 7: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

7

Outline of session

Criteria for authorship

Problems with authorship

Practical dilemmas

Page 8: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

8

Why have authorship?

Recognition Job, grants, promotions

Accountability Vouch for results and conclusions Prevent fabrication, fraud, plagiarism

Page 9: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

9

Criteria for authorship

Conception and design or data

analysis and interpretation, AND

Drafting or revising article for

important intellectual content, AND

Approving final manuscript

Page 10: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

10

Criteria for authorship

Not merely

Funding or equipment

Collection of data

Supervision of research group

Page 11: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010
Page 12: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

12

Implications of authorship

Take responsibility for at least one

component

Identify who is responsible for each

component

Confidence in co-authors ability and

integrity

Page 13: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

13

Problems with authorship

1. Publish articles that shouldn’t be

published False, fabricated data Duplicate publications

Page 14: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

14

Duplicate publication

Articles in systematic reviews 1234

Duplicate 103 (8%)

No cross reference 63%

Translations 12%

JAMA 2004; 291: 974

Page 15: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

15

Types of duplication

Identical sample and outcomes

Combine several articles

Report different outcomes on sample

New data added to preliminary article

Part of larger trial, same outcomes

Page 16: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

16

What is wrong with multiple publications?

Inefficient transfer of information

Bias in evidence base for systematic

reviews

Page 17: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

17

Problems with authorship

2. Fail to publish articles that should be Negative results

3. Too many authors = honorary authors People listed who shouldn’t be

4. Too few authors = ghost authors People omitted who should be authors

Page 18: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

18

Advantage study (2003)

Randomized trial of 5557 patients

Refecoxib vs. naproxen

Discontinue Rx for GI reasons: 5.9%

vs. 8.1%

Page 19: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

19

Advantage study

MIs: 5 on rofecoxib vs. 1 on naproxen 3 additional rofecoxib deaths not reported

Page 20: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

20

Statement by 1st author

“Merck designed the trial, paid for the trial, ran

the trial. . . Merck came to me after the study

was completed and said, ‘We want your help

to work on the paper.’ The initial paper was

written at Merck, and then was sent to me for

editing”

Page 21: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

21

Requirements for industry-sponsored research

Full responsibility for trial Design of study Access to data

• Independent statistician

Data analysis

Control over publication Including data detrimental to product

Page 22: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

22

Requirements for industry-sponsored research

Disclose financial relationships Including payment for writing

Page 23: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

23

Ghostwriting

Asked by medical education company

to write a review paper on interactions

between warfarin and dietary

supplements sponsored by drug

company

JGIM 2005; 20: 546

Page 24: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

24

Ghostwriting

Received draft article, with name on

title page

Company developing oral

anticoagulant No mention of product Biased against warfarin

Page 25: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

25

Ghostwriting

Later asked to review same paper No mention of ghost author No mention of drug company sponsorship

Page 26: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

Are these isolated cases?

26

Page 27: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

27

Problematic authorship

Honorary authors 21%

Ghost authors 13%

Ghosts acknowledged 0%

JAMA 1998; 280:222

Page 28: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

28

Problematic authorship

No substantial contributions26%

Provided subjects, materials,

lab, technical assistance 58%

Collected data 25%

JAMA 1994; 271: 438

Page 29: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

29

Preventing ghost authorship

All persons who had input into writing

must be author or acknowledged

All persons named as authors or

acknowledged must complete financial

disclosure

Page 30: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

30

Problems with authorship

5. Authors in wrong positions

Page 31: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

31

Who’s on second?

Less prestige than first

Middle authors contribute even less

Last author often senior

Not cited after 6th

Page 32: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

32

Survey of department chairs

Fictitious article and authors

Infer author’s contributions

Epidemiology 2004; 15; 125

Page 33: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

33

Contributions of authors

“Little idea of roles of any author”

If corresponding author, more credit

Page 34: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

34

Documentation of authorship

Describe specific contributions In manuscript In promotion packet

Page 35: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

Relationships among authors

35

Page 36: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

36

Paper on predictive model for HIV genotyping

1. Medical student

2. Former industry scientist, now at FDA Lawsuit against former company

3. Biostatistician

4. Programmer

5. You

Page 37: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

37

2nd author

Demanding and persistent in opinions

Revisions a “marathon”

Decisions not to accept his advice =

disregard his opinion “Accusatory and insulting”

Page 38: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

38

Paper has 4 rejections

2nd author wants to reframe the paper More on advances in predictive models

Page 39: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

39

Concerns of senior author

Get the article published somewhere Want to influence practice guidelines

Get medical student a publication for

internship applications

Minimize time and hassle

Page 40: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

40

Plan

One round of discussions

Senior author writes revision

Give authors option of accepting final

draft or withdrawing as author

Page 41: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

Suggestions

Like “problem patient” Listen to concerns and expectations Address emotional issues explicitly Set boundaries Get agreement on process

Dissenting section of paper An alternative interpretation …

41

Page 42: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

Suggestions

Mediation

42

Page 43: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

43

Concussions in NFL players

Retrospective review of data from team

physicians

Return to play not associated with

increased risk of second concussion

Page 44: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

44

Conclusion

“Might be safe for college/high school

football players to be cleared to return

to play on the same day as the injury”

“Keep an open mind to possibility that

present analysis of professional

football players may have relevance to

college and high school players.”

Page 45: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

45

Dispute among 5 authors

Two disagreed

One said passage added without her

knowledge

Page 46: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

46

Lead author

Proofs were sent to each author No need to point out new passage

“If people who are not scientists or

physicians are misinterpreting it, that

is not the responsibility of those who

wrote it.”

Page 47: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

47

Case 1: Prior agreements fail

What would you do? Send an ultimatum to your colleague Get your mentor to pressure him Forget about the project and move on Not sure

Page 48: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

48

Excuses

It’s in the pipeline

It’s next in the pipeline

BMJ 1994; 309: 1739

Page 49: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

49

Excuses

I’m reanalyzing the data

The data are on a Windows computer

I can’t find the right statistical test to

prove it worked

Page 50: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

50

Pragmatic concerns

Power differences

Future repercussions

Is it worth the hassle?

Can you live with yourself?

Page 51: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

51

Just do it, diplomatically

“I know you’re very busy. I’m willing to

take over as 1st author and write a

draft.”

“If I haven’t heard in 3 weeks, I’ll

assume you’re too busy to be first

author.”

Page 52: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

52

Case 2: Added author

What would you do? Hold your nose and do it Refuse and stand up for your principles Ask your department chair to intervene

Page 53: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

53

Just say no, diplomatically

“The journal insists that all authors

sign that they have met a list of

requirements. I would feel very

awkward signing this. I’d like your

permission to give you a big thank you

in the acknowledgments.”

Page 54: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

Emotional impact of authorship disputes

After disputes commonly feel:

Angry

Hurt

Taken advantage of

54

Page 55: 1 Authorship Bernard Lo, M.D. August 23 and September 2, 2010

55

Take home points

Be explicit about authorship positions

and responsibilities

Spell out arrangements in advance